Detalles de la búsqueda
1.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Lancet Oncol
; 17(2): 200-211, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26655421
Resultados
1 -
1
de 1
1
Próxima >
>>